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Abstract
Background: There have been no reports discussing which imaging procedures are truly necessary before treatment 
of endoscopically-diagnosed early gastric cancer (eEGC). The aim of this pilot study was to show which imaging 
examinations are essential to select indicated treatment or appropriate strategy in patients with eEGC.
Methods: In 140 consecutive patients (95 men, 45 women; age, 66.4 +/- 11.3 years [mean +/- standard deviation], 
range, 33-90) with eEGC which were diagnosed during two years, the pre-treatment results of ultrasonography (US) 
and contrast-enhanced computed tomography (CT) of the abdomen, barium enema (BE) and chest radiography (CR) 
were retrospectively reviewed. Useful findings that might affect indication or strategy were evaluated.
Results: US demonstrated useful findings in 13 of 140 patients (9.3%): biliary tract stones (n = 11) and other malignant 
tumors (n = 2). Only one useful finding was demonstrated on CT (pancreatic intraductal papillary mucinous tumor) but 
not on US (0.7%; 95% confidential interval [CI], 2.1%). BE demonstrated colorectal carcinomas in six patients and polyps 
in 10 patients, altering treatment strategy (11.4%; 95%CI, 6.1-16.7%). Of these, only two colorectal carcinomas were 
detected on CT. CR showed three relevant findings (2.1%): pulmonary carcinoma (n = 1) and cardiomegaly (n = 2). 
Seventy-nine patients (56%) were treated surgically and 56 patients were treated by endoscopic intervention. The 
remaining five patients received no treatment due to various reasons.
Conclusions: US, BE and CR may be essential as pre-treatment imaging examinations because they occasionally 
detect findings which affect treatment indication and strategy, although abdominal contrast-enhanced CT rarely 
provide additional information.
Background
Gastric cancer is one of the leading causes of cancer mor-
tality worldwide and one of the most common malignant
tumors in Japan. However, in early gastric cancer (EGC),
curative treatment is possible and the five-year survival
rate for EGC patients has reached 90% or greater accord-
ing to not only Japanese but also European series [1-5].
EGC is defined as a cancer confined to the mucosa (m) or
submucosa (sm) regardless of lymph node metastasis
[6,7]. Availability of cancer screening and improved
awareness of the disease has led to increased detection of
EGC.
In EGC, the incidence of distant metastasis at initial
diagnosis is extremely low [1], but most gastroenterolo-
gists simply assume that contrast-enhanced computed
tomography (CT) of the abdomen is essential as a routine
pre-treatment imaging examination. However, most diag-
nostic radiologists feel it is rare for pre-treatment abdom-
inal CT to demonstrate metastatic disease which alters
indicated treatment or appropriate strategy. Many benign
conditions which may affect surgical procedure, such as
biliary tract stones or abdominal aortic aneurysms, can
usually be demonstrated by abdominal ultrasonography
(US).
Surprisingly, there have been no reports discussing
which imaging procedures are truly necessary before
treatment of EGC. The aim of this study was to define the
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essential pre-treatment imaging examinations in patients
with endoscopically-diagnosed EGC (eEGC).
Methods
Subjects
In a referral hospital of Gunma University Hospital (Ise-
saki Municipal Hospital, Isesaki, Japan) we retrospec-
tively reviewed patient charts in which pre-treatment
diagnosis of eEGC was made between July 2004 and June
2006. The inclusive criteria were 1) diagnosis of EGC
made by endoscopic inspection and endoscopic ultra-
sonography (EUS) performed by an experienced endos-
copist, and 2) diagnosis of adenocarcinoma made on
pathological specimens obtained by punch biopsy during
endoscopic examination. Some eEGCs had a final diagno-
sis of advanced gastric cancer after surgical resection, but
postoperative diagnosis was not a criterion of case selec-
tion. 140 patients (95 men and 45 women; age 66.4 +/-
11.3 years [mean +/- standard deviation], range 33-90)
met these criteria.
Imaging procedures
Contrast-enhanced abdominal CT was performed using
an eight-detector row CT scanner (LightSpeed Plus-U;
GE-Yokokawa, Tokyo, Japan). Followed by a non-
enhanced upper abdominal CT from the diaphragmatic
dome to the lower edge of the kidney, a contrast-
enhanced CT was performed from the diaphragmatic
dome to the anus using nonionic contrast material (80 ml
of iopamidol 300 mgI/ml in patients with 48 kg of body
weight or less; 100 ml of iopamidol 300 mgI/ml in
patients 48-60 kg; 100 ml of iopamidol 370 mgI/ml in
patients 60-74 kg; 150 ml of iohexiol 300 mgI/ml in
patients 74 kg or greater). Contrast material was intrave-
nously administered by bolus injection using a power
injector and scanning was started 100 seconds after the
initiation of contrast material injection. The scan param-
eters for CT were as follows: section thickness, 1.25 mm;
pitch 1.35; reconstruction interval, 7.5 mm; tube rotation
time, 0.5 sec.
Abdominal US examination was performed after over-
night fasting by an experienced sonographer (five or
more years of experience) using commercially available
scanners (SSD-2000, ALOKA, Tokyo, Japan) with stan-
dard transducers (3.5 MHz curvilinear array prove). All
abdominal organs were carefully scanned, and any abnor-
mal findings were recorded on hard copies.
Barium enema (BE) examination was performed using
standard procedure. Chest radiograph (CR) was obtained
on a conventional supine PA view. All CT, US, BE and CR
images were interpreted by one of two board-certified
diagnostic radiologists (EH or MT), and final imaging
diagnoses were reported. The order in which CT, US, BE
and CR were performed was random, and each study was
independently interpreted.
Data review
One of the authors (EH) reviewed all patient charts,
including results of CT, US, CR, BE, blood cell counts and
laboratory data. For purposes of this study, we noted
findings which would change the treatment indication or
strategy, i.e. 1) distant metastasis, particularly liver
metastasis, 2) malignant tumors other than gastric can-
cer, and 3) any other findings which might affect indi-
cated treatment or appropriate strategy such as an
abdominal aortic aneurysm and biliary tract stones. Any
abnormal findings which would change indicated treat-
ment or strategy were recorded.
Our institutional review board does not require its
approval or informed patient consent for this type of ret-
rospective study. The Declaration of Helsinki principles
were followed.
Statistical analysis
Data was expressed by mean +/- standard deviation (SD).
If necessary, 95% confidential interval (CI) was calcu-
lated. Binominal distribution was employed for the 95%
CI, when appropriate. Usually, np and n(1-p) must both
exceed about 5, where p is the proportion of the observed
sample having the attribute of interest, and n is the num-
ber observed. When it was not possible to use this
approximation, we calculated the upper 95% confidence
bound on the basis of the binominal distribution [8].
Results
Treatment selection, pathological diagnosis and patient 
prognosis
Of 140 patients included in this study, 79 patients (56%)
were treated surgically, 51 (36%) by endoscopic mucosal
resection (EMR), and five (3.6%) by endoscopic micro-
wave coagulation therapy (EMCT). The remaining five
patients (3.6%) received no treatment due to patient
refusal (n = 3), advanced age (n = 1) or myelodysplastic
syndrome (n = 1).
Eight of 79 surgically resected cancers had a pathologic
diagnosis of advanced gastric cancer (tumor invasion of
the muscularis propria [mp]). Nine patients had patho-
logically positive N1 lymph node metastasis, and one
patient had N2 lymph node metastasis. No N3 lymph
node metastasis, liver metastasis, or peritoneal dissemi-
nation was observed during laparotomy. Post operative
clinical stage of gastric cancers were T1(m)N0 (n = 35),
T1(sm)N0 (n = 29), T1(m)N1 (n = 1), T1(sm)N1 (n = 6),
T2N0 (n = 5), T2N1 (n = 2) and T2N2 (n = 1). One of the
surgical cases included a post EMR case whose patholog-
ical diagnosis was m, but had suspected to have perfora-Horisoko et al. BMC Medical Informatics and Decision Making 2010, 10:33
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tion during the EMR procedure. All 51 gastric cancers
treated by only EMR were pathologically proved mucosal
cancers, and no additional gastrectomies were per-
formed. EMCT (n = 5) is a tumor destructive therapy
which does not allow pathological confirmation of the
depth of tumor invasion. However, there were no cases of
local recurrence during follow up of one year or longer.
For the operated cases, final histopathological diagnosis
were well differentiated tubular adenocarcinoma (n = 32),
moderately differentiated tubular adenocarcinoma (n =
16), poorly differentiated adenocarcinoma (n = 14) and
signet ring cell carcinoma (n = 17). The T1(m)N1 lesion
was signet ring cell carcinoma. For the EMR cases, final
histopathological diagnosis were well differentiated tubu-
lar adenocarcinoma (n = 45) and moderately differenti-
ated tubular adenocarcinoma (n = 6).
All 135 patients who received treatment were followed
on an outpatient basis (follow-up period 7-36 months:
22.8 +/- 6.64). Three patients died during this period due
to bone metastasis (n = 1) of gastric cancer, advanced
colon cancer (n = 1) or hepatocellular carcinoma (n = 1).
The other 132 patients were alive without any evidence of
recurrent disease.
Imaging findings and changes in treatment indication and 
strategy
The imaging examinations performed before treatment
are summarized in Table 1. Abdominal contrast-
enhanced CT was performed in 92% of cases, and US was
performed on over half of the patients. However, nine
patients (6.4%) underwent neither CT nor US.
Abnormal findings demonstrated on CT or US which
would potentially affect treatment indication or strategy
are shown on Table 2. Biliary stones were identified in 14
patients (eight on CT and 11 on US). Three patients who
had biliary stones underwent CT but not US. In all 14
patients, gastrectomy with simultaneous cholecystec-
tomy was the chosen form of treatment. Other CT find-
ings which would potentially affect treatment indication
or strategy were one hepatocellular carcinoma and one
renal cell carcinoma, but these two findings were also
well demonstrated on US. A pancreatic tumor (intraduc-
tal papillary mucinous tumor) was detected by CT but
not by US, even though both were performed. This is the
only case in which CT demonstrated a potentially strat-
egy-altering lesion which was not identified by US (0.7%;
95% CI, 2.1%).
Some CT and US findings did not change treatment or
strategy: CT found suspicion of lymphadenopathy
( l y m p h  n o d e  w i t h  a  m a x i m u m  d i a m e t e r  o f  1  c m  o r
greater) [9], in the upper abdomen (N1) in eight patients.
Abdominal US failed to depict all of these lesions. These
lesions were not considered to be strategy-altering
because none of the cases matched the criteria for EMR
or EMCT on endoscopic examination, and they all
underwent gastrectomy. Of theses, only one patient was
pathologically confirmed to be N1. In fact, 10 of 79 surgi-
cally treated patients had pathologically positive lymph
nodes in the upper abdomen, but the above described
patient was the only case in which lymph node metasta-
ses was accurately diagnosed preoperatively. In seven
patients, cavernous hemangiomas of the liver were sus-
pected on US. In all seven, the diagnosis was confirmed
by contrast-enhanced CT. These lesions were not consid-
ered to be strategy-altering.
BE demonstrated colorectal carcinomas in six patients
and polyps in 10 patients (Table 2). Of the colorectal can-
cers, only two were demonstrated on CT . CT detected
none of the colon polyps identified by BE. These lesions
of the colon (16 of 140 patients, 11.4%: 95% CI, 6.1-16.7%)
altered treatment strategy in that surgical resection of the
colorectal cancers were performed simultaneously to gas-
trectomy, and colonic polyps were resected endoscopi-
cally.
CR findings altered treatment in three patients. Cardio-
megaly was identified in two patients, and additional pre-
treatment examinations were performed, finding cardiac
disease which contraindicated surgical gastrectomy.
Endoscopic findings of these patients fortunately met
EMR criteria. CR also identified one primary adenocarci-
noma of the lung, which was confirmed by chest CT and
r e s e c t e d  a f t e r  g a s t r e c t o m y .  N o  l u n g  m e t a s t a s i s  w a s
detected by CR.
In one case (0.71%), diffuse bone metastasis was diag-
nosed by bone scintigraphy. This study was performed
because of markedly elevated cerium alkaline phos-
phatase (ALP) level. Both CT and CR failed to make this
diagnosis.
Discussion
In our series, abdominal US and BE occasionally provided
useful information which may change the treatment indi-
cation or strategy for eEGC, thus they may be considered
as routine pre-treatment imaging examinations. How-
ever, it was rare for useful information which would alter
indicated treatment or strategy to be provided by con-
trast-enhanced abdominal CT.
Table 1: Imaging examinations before treatment (n = 140)
Examinations No. of cases performed
CT 129 (92%)
US 74 (53%)
BE 75 (54%)
CR 140 (100%)
In nine patients (6.4%), in whom endoscopic treatments were 
selected, neither CT nor US were performed.Horisoko et al. BMC Medical Informatics and Decision Making 2010, 10:33
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Lymph node metastasis is the most important prognos-
tic factor for patients with EGC [1-3,10], but once the
endoscopic diagnosis of EGC is made, the presence of
swollen lymph nodes in the upper abdomen does not
affect indication. Indication for endoscopic therapies
such as EMR and EMCT is determined by tumor histol-
ogy, depth and size (mucosal cancer less than 2 cm with-
out ulceration). Since it has been reported that lymph
node metastasis is extremely rare in such small mucosal
cancers [2,5,10-12], clinicians will not entertain the possi-
bility of lymphadenopathy. If the EGC does not meet the
above criteria for endoscopic treatment, gastrectomy
with D2 lymph node dissection is performed, and indica-
tion for modified gastretomy is determined by intraoper-
ative findings [5]. Added to the fact that N3 metastasis of
EGC is extremely rare [10-12], detailed preoperative eval-
uation of lymph nodes is not essential.
Distant metastasis of EGC is extremely rare, as is syn-
chronous liver metastasis [1]. However, since the liver is
the most common site of gastric cancer metastasis [13],
evaluation of the liver is necessary. In our series, however,
no liver metastasis was depicted in any patients with
eEGC on either CT or US as predicted. Radiologic studies
may also have a potential role in detecting unrelated
abnormalities which may affect indicated treatment or
strategy. Some abdominal findings such as malignant
abdominal tumors and biliary tract stones may be impor-
tant because it opens the possibility of synchronous of
surgical intervention. Fourteen (10%) of 140 patients had
biliary stones. There were patients in our series who had
biliary stones detected on CT and did not undergo US.
However, It is not unrealistic to speculate US would have
been sufficient to detect these stones.
Nine patients had other synchronous malignant tumors
(6.4%) and six of them (4.3%) were colorectal carcinoma.
According to a follow-up study of 1475 patients of EGC
[1], 48 (3.3%) patients died due to other malignant dis-
eases (18-186 month observation period), and the most
common malignancy was colorectal carcinoma (0.7%; n =
11), so we found the high incidence of colorectal carci-
noma in our series surprising [14].
To the best of our knowledge, it is not known whether
synchronous surgical intervention of these diseases may
provide better prognosis or quality of life, but we suspect
avoiding re-laparotomy is appropriate in most cases, due
to increased difficulty of the procedure and potential
complications. Our results suggested that abdominal US
and BE may be essential as pre-treatment imaging exami-
nations for patients with eEGC. CR may also be neces-
sary, since it can reveal serious conditions which may
affect treatment indication or strategy, such as cardiopul-
monary disease as well as lung cancer. Radiation exposure
and cost of CR are low, so we can recommend its use as a
routine pre-treatment examination. The cost of abdomi-
nal CT depends on the country, but it is more expensive
than CR, and, according to the literature, the effective
radiation dose of abdominal CT is around 20mSv [15,16],
which is, again, much greater than that of CR. Omission
of contrast-enhanced abdominal CT in patients with
EGC would have the benefit of reduced cost and radia-
tion exposure.
In one patient, diffuse bone metastasis was present at
the initial diagnosis. We believe this case was extremely
exceptional, since only 14 cases of EGC with synchronous
bone metastasis have been reported in English literature
[17]. According to the literature, elevated ALP can be an
Table 2: Abnormal findings demonstrated by imaging examinations, which may affect treatment indication or strategy for 
eEGC
Abnormal findings No. of patients Modality
CT US BE CR
Biliary tract stone *a) 14 8 11 - -
H e p a t o c e l l u l a r  c a r c i n o m a  * c ) 111- -
R e n a l  c e l l  c a r c i n o m a  * c ) 111- -
Pancreatic IPMT *b) *c) 1 1 0 - -
C o l o r e c t a l  c a r c i n o m a  * c )6206-
Colorectal polyp (benign) *c) 10 0 0 10 -
Pulmonary adenocarcinoma *c) 1 - - - 1
C a r d i o m e g a l y 2---2
a) In 11 of 14 patients gallstones were confirmed on US. In the other three patients gallstones were confirmed by CT, but no abdominal US 
were performed. CT did not demonstrated gallstones in three patients, in whom gallstones were confirmed by US.
b) Intraductal papillary mucinous tumor.
c) All were pathologically proven.Horisoko et al. BMC Medical Informatics and Decision Making 2010, 10:33
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effective marker for bone metastasis, as it was in this case
[17].
This study has several limitations: First, the number of
subjects included in this study was small. In addition,
since this was a retrospective study, not all examinations
were performed in all patients. It is too early to conclude
that pre-treatment contrast-enhanced abdominal CT can
be omitted for the patients with eEGC, and prospective
studies with a larger number of patients are clearly
required to confirm our results. Secondly, BE was used to
screen for colorectal carcinoma in this study, as was the
practice in our institution during the study period. Cur-
rent practice may favor colonoscopy as a screening exam-
ination. Thirdly, we did not evaluate the usefulness of US
or CT in depicting ovarian metastasis from eEGC. How-
ever, only seven cases of EGC with a Kruckenberg tumor
have been reported in the literature [18,19]. Finally, there
were eight cases in which the postoperative diagnoses
were advance gastric cancer (mp invasion). However, it
has been reported that surgery with D2 lymph node dis-
section for mp gastric cancer can provide a cure rate sim-
ilar to that for EGC [20], and well-trained endoscopists
can accurately distinguish EGC from more invasive
tumors by routine endoscopy alone in 90% of patients
[21-23].
Conclusions
For the patients with eEGC, abdominal US, BE and CR
may be essential as pre-treatment imaging examinations
because they occasionally detect findings which affect
treatment indication and strategy. It was rare for con-
trast-enhanced abdominal CT to provide additional
information. And it may be possible to eliminate con-
trast-enhanced abdominal CT as a preoperative examina-
tion, at least for patients receiving EMR. For gastric
cancers with suspected sm invasion, the possibility of
lymph node metastasis is high enough to warrant further
investigation regarding the value of preoperative con-
trast-enhanced abdominal CT before declaring it entirely
unnecessary.
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